Verified Events
DateTypeCompanyHeadlineSegment
Stryker joins Gil Hospital’s planned smart-orthopaedics programme
- The diagnostic workflow will analyse knee and lower-limb X-rays with AI.
- Surgery plans combine patient-specific 3D CT analysis, robotic-arm cutting and haptic technology.
- Rehabilitation will use mobile devices to support personalised exercises.
Intuitive Ion passes 10,000 robotic bronchoscopies in Europe
- More than 1,000 Ion systems are installed in hospitals worldwide.
- Physicians used Ion for more than 140,000 lung biopsies globally during 2025.
- The shape-sensing catheter is designed to reach peripheral lung nodules and stabilise biopsy tools.
Zimmer Biomet extends THINK Surgical TMINI distribution agreement
- The exclusive wireless, handheld TMINI configuration is compatible with Zimmer Biomet’s Persona Knee System.
- The extension follows the initial agreement’s successful term and supports continued U.S. surgeon access to the system.
Intuitive da Vinci SP used in four-part breast surgery at MedStar Georgetown
- The patient was a 50-year-old woman with early-stage breast cancer.
- The approach is intended for selected patients with small to moderate breast size, a healthy body weight and appropriately positioned nipples.
XCath’s Iris surgical robot enters FDA TAP programme
- Enrollment follows Iris’s September 2, 2026 Breakthrough Device designation.
- A dedicated FDA advisor and review-team engagement will cover development decisions, with facilitated input from payers, providers and other stakeholders.
- Iris remains under development and is not cleared for commercial distribution in any country.
MMI raises $125 million Series D for Symani commercial expansion
- Approximately 50 Symani systems are installed, with 3,500 complex microsurgical procedures performed worldwide.
- Proceeds support expansion in the United States and other markets, clinical evidence including REMIND, and energy-instrument and digital-surgery development.
Parallel Robotics discloses $7.31M securities sale including note conversion
- Preferred shares issued on conversion of approximately $6.31 million in promissory notes are included in the securities sold.
- The offering included 32 investors and a $250,000 minimum investment for outside investors.
- The Ann Arbor company develops MediBot, a handheld device for suturing and knot-tying during minimally invasive surgery.
Redefine Surgery closes oversubscribed pre-seed financing
- The company described the investor base as predominantly surgeons.
- Proceeds support development of its portable surgical-intelligence platform ahead of commercialization.
- Its initial orthopedic focus includes computer-vision guidance and robotic assistance; the platform remains under development and subject to clearance.